> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Cigna's new CEO delivers $71.7B quarter, raises guidance
- URL: https://members.americanhealthintel.com/2026-07-30-ledger/
- Published: 2026-07-31T03:05:25.000Z
- Updated: 2026-07-31T03:05:25.000Z
- Description: Plus: J&J cuts 2026 guidance after Firefly Bio buy, Sail Biomedicines option. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: J&J cuts 2026 guidance after Firefly Bio buy, Sail Biomedicines option. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Ledger Thursday, July 30, 2026 Cigna's new CEO delivers $71.7B quarter, raises guidance Plus: J&J cuts 2026 guidance after Firefly Bio buy, Sail Biomedicines option. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Earnings Confidence: High Cigna, the health insurer and pharmacy benefits giant, posted a $71.7 billion quarter in the first earnings report under its new CEO, beating Wall Street's revenue and profit estimates and raising its full-year guidance. Revenue hit $71.7 billion, up 7%. Adjusted earnings per share of $7.78 beat estimates. The catch: its medical cost ratio, the share of premiums spent on care, climbed to 84.5% from prior-year risk adjustments in individual plans. Why it matters This is the first scorecard on Cigna's new CEO, and the numbers came in strong, but watch the medical care ratio for signs of rising costs across the industry. Sources: [SEC](https://www.sec.gov/Archives/edgar/data/0001739940/000114036126017971/ef20071317%5Fex99-1.htm?ref=members.americanhealthintel.com) · [Forbes](https://www.forbes.com/sites/brucejapsen/2026/07/30/as-new-ceo-takes-charge-cigna-reports-17-billion-quarterly-profit/?ref=members.americanhealthintel.com) Deal Confidence: High Johnson & Johnson, the drugmaker behind Stelara and Darzalex, cut its own 2026 profit forecast today after completing a $1 billion buyout of an oncology biotech and taking an option on a second one focused on autoimmune disease. The combined Firefly Bio and Sail Biomedicines deals will cut adjusted earnings per share by about 64 cents this year. Sail's technology reprograms immune cells inside the body without lab-grown cell manufacturing. Why it matters J&J chose to absorb a near term profit hit to buy into next-generation cancer and autoimmune disease technology, a bet that the science pays off later even as this year's numbers take a hit. Sources: [Jnj](https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-collaboration-with-sail-biomedicines-to-advance-in-vivo-car-t-programs-and-transform-autoimmune-disease-through-immune-reset?ref=members.americanhealthintel.com) · [SEC](https://www.sec.gov/Archives/edgar/data/0000200406/000020040626000163/jnj-20260729.htm?ref=members.americanhealthintel.com) Also today Ventas nearly doubles senior housing investment target to $4.5B [Read](https://americanhealthintel.com/editions/2026-07-30-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#ventas-q2-2026-senior-housing-investment-raise) UHealth and UnitedHealthcare down to 1 day before deadline [Read](https://americanhealthintel.com/editions/2026-07-30-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#uhealth-unitedhealthcare-contract-standoff) Included Health acquires Firefly Health to scale alternative health plans [Read](https://americanhealthintel.com/editions/2026-07-30-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#included-health-firefly-health-acquisition) FRONTIER SCAN: Grifols posts profit growth while closing US donor centers [Read](https://americanhealthintel.com/editions/2026-07-30-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#grifols-plasma-industry-h1-2026-frontier-scan) 318Records$19.6BEnforcement15Deadlines95Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-07-30-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |